DSM Tensvida Ingredients Awarded for Innovation
tensVida has already received multiple international industry recognitions, including the NutrAward for most innovative, evidence-based health and nutrition ingredient at Nutracon 2009, the Gold Award for the best innovation in health ingredients at HiE 2008, and two finalist positions at Drinktec 2009.
6 Nov 2009 --- DSM’s lactotripeptide blood pressure management ingredient, tensVida1 , has received another accolade with a win at this year’s European Outsourcing Awards. Judges in the category of Outstanding Application in Nutraceuticals commended DSM’s strategy for developing and launching tensVida with a highly innovative approach. This latest award for tensVida recognises the close collaboration between DSM and its expert partners. DSM worked closely with the University of Maastricht, a large dairy company, a prominent consumer products company and TNO, a leading independent Dutch research organisation.
Garnet Pigden, Sr. Vice President-Functional Foods, DSM Nutritional Products, comments: “The award further highlights DSM’s commitment to research, open innovation and science-based product development. We are encouraged by the response to tensVida to date and are very pleased to receive this recognition. Our integrated approach was crucial to achieving success, particularly as extensive research, product development and new manufacturing processes were required.”
tensVida has already received multiple international industry recognitions, including the NutrAward for most innovative, evidence-based health and nutrition ingredient at Nutracon 2009, the Gold Award for the best innovation in health ingredients at HiE 2008, and two finalist positions at Drinktec 2009.
Maintaining cardiovascular health is currently the number one global health concern and through DSM’s extensive consumer research the need for an effective solution was identified. tensVida combines comprehensive scientific studies with in-depth consumer research to meet this need. tensVida contains specific, naturally-occurring dairy peptides called lactotripeptides which have been shown to help control blood pressure in multiple clinical studies. The active peptide responsible for lowering blood pressure is the so-called lactotripeptide Isoleucine-Proline-Proline (IPP). Although lactotripeptides are present in normal dairy products, they are inactive within the original milk protein. DSM developed innovative enzymatic technology to release and activate the peptides.
Designed to provide activated lactotripeptides in a highly concentrated and convenient form, tensVida is effective at low doses. Moreover, with the benefit of a clean taste, tensVida is suitable for a broad range of applications, including dietary supplements, waters, juices, cereal bars and yoghurts.
